---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-021961"
form_type: "8-K"
ticker: "CING"
cik: "0001862150"
company_name: "Cingulate Inc."
filed_at: "2022-08-11T23:59:59+00:00"
generated_at: "2026-06-24T01:08:12.983174+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Cingulate Q2 net loss $4M, secures $5M insider debt, adds ADHD expert to board

## Summary
- Q2 2022 net loss $4.0M (vs $1.4M Q2 2021); six-month net loss $9.0M (vs $2.8M).
- Cash $8.2M at June 30, 2022, down from $16.5M Dec 2021; expects to fund through Q1 2023.
- Secured $5M unsecured debt from Werth Family Investment at 15% interest, due 2025; quarterly call option from Apr 2023.
- Appointed Scott Applebaum to board; brings 10+ years ADHD expertise from Shire (Adderall XR, Vyvanse).
- CTx-1301 Phase 3 pediatric trial dosing H2 2022, results H2 2023; company needs ~$16.5M additional capital for NDA.

## SEC filing metadata
- accession: 0001493152-22-021961
- form_type: 8-K
- ticker: CING
- cik: 0001862150
- company_name: Cingulate Inc.
- filed_at: 2022-08-11T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 2.02, 2.03, 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1862150/000149315222021961/0001493152-22-021961-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1862150/000149315222021961/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-021961
- JSON: https://secwatch.observer/filing/0001493152-22-021961.json
- Plain text: https://secwatch.observer/filing/0001493152-22-021961.txt

## Key facts
- Executive change
  Scott Applebaum was appointed as Class III Director at Cingulate Inc..
  - Action: appointed
  - Role: Class III Director
  source text: On August 9, 2022, the Board, upon the recommendation of the Nominating and Corporate Governance Committee, expanded the size of the Board to eight directors and appointed Scott Applebaum as a Class III director to serve until the Company’s 2024 annual meeting of stockholders.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1862150/000149315222021961/0001493152-22-021961-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.